Skip to main content
SpringerLink
Log in
Book cover

Developing Drug Products in an Aging Society pp 23–44Cite as

Healthcare Provision in an Aging Society—The European Perspective

  • Chapter
  • First Online:

  • 1331 Accesses

Part of the book series: AAPS Advances in the Pharmaceutical Sciences Series ((AAPS,volume 26))

Abstract

This chapter aims to set out an overview of current practice for the treatment of older patients in Europe. It focuses on established health services for the elderly and current prescribing practice in the context of European health policy. It details the roles of the professional health bodies within Europe including the European Medicines Agency (EMA) and European Union Geriatric Medicine Society (EUGMS) and patient charters including that of the PREDICT partnership. It explores some of the overprescribing and underprescribing issues in older people specific to Europe. The healthcare system for older people in England is described in some detail and compared to a number of other European countries, thereby providing a context for prescribing opportunities and challenges in the continent.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Eurostat. Mortality and life expectance statistics. 2015. Available from: http://ec.europa.eu/eurostat/statistics-explained/index.php/Mortality_and_life_expectancy_statistics. Accessed Aug 2015.

  2. Eurostat. Fertility statistics. 2015. Available from: http://ec.europa.eu/eurostat/statistics-explained/index.php/Fertility_statistics. Accessed Aug 2015.

  3. Eurostat. Population structure and ageing. 2015. Available from: http://ec.europa.eu/eurostat/statistics-explained/index.php/Population_structure_and_ageing. Accessed Aug 2015.

  4. Eurostat. Healthy life years statistics. 2015. Available from: http://ec.europa.eu/eurostat/statistics-explained/index.php/Healthy_life_years_statistics. Accessed Aug 2015.

  5. Cornwell J, et al. Continuity of care for older hospital patients: a call for action. London, England: King’s Fund; 2012.

    Google Scholar 

  6. European Commission. Dutch National Institute for Public Health and Environment (RVIM). In: Harbers MM, Achterberg PW, editors. Europeans of retirement age: chronic disease and economic activity; 2012. Report number—No SC 2011 62 51, implementing Framework Contract No EAHC/2010/Health/01 (Lot 1).

    Google Scholar 

  7. Alzheimer’s Society. Statistics. 2015. Available from: http://www.alzheimers.org.uk/site/scripts/documents_info.php?documentID=341. Accessed May 2–15.

  8. Alzheimer Europe. The prevalence of dementia in Europe. 2015. Available from: http://www.alzheimer-europe.org/Policy-in-Practice2/Country-comparisons/The-prevalence-of-dementia-in-Europe. Accessed June 2015.

  9. Stroke Association, UK. About stroke. 2015. Available from: http://www.stroke.org.uk/about-stroke. Accessed May 2015.

  10. Engstad T, Engstad TT, Viitanen, M, Ellekjær H. Epidemiology of stroke in the elderly in the Nordic countries. Incidence, survival, prevalence and risk factors. Nor Epidemiol 2012;22(2):121–6.

    Google Scholar 

  11. OECD. Health at a glance. Europe: OECD Publishing; 2010. Available from: http://ec.europa.eu/health/reports/docs/health_glance_en.pdf. Accessed Sept 2015.

  12. National Service Framework for Older People. 2001. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/198033/National_Service_Framework_for_Older_People.pdf. Accessed Sept 2015.

  13. Spinewine A, Swine C, Dhillon S, et al. Appropriateness of use of medicines in elderly inpatients: qualitative study. BMJ. 2005;331:935–9.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Fialová D, Topinková E, Gambassi G, Finne-Soveri H, Jónsson PV, Carpenter I, Schroll M, Onder G, Sørbye LW, Wagner C, Reissigová J, Bernabei R. AdHOC Project Research Group Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005;293:1348–58.

    Google Scholar 

  15. Harari D, et al. Proactive care of older people undergoing surgery (‘POPS’): designing, embedding, evaluating and funding a comprehensive geriatric assessment service for older elective surgical patients. Age Ageing. 2007;36:190–6.

    Article  PubMed  Google Scholar 

  16. Marcantonio ER, et al. Reducing delirium after hip fracture: a randomized trial. J Am Geriatr Soc. 2001;49(5):516–22.

    Article  CAS  PubMed  Google Scholar 

  17. Gov.UK. Delivering better integrated care. 2015. Available from: https://www.gov.uk/guidance/enabling-integrated-care-in-the-nhs. Accessed Sept 2015.

  18. London, England. King’s Fund. Population Health systems—going beyond integrated care. 2015. Available from: http://www.kingsfund.org.uk/sites/files/kf/field/field_publication_file/population-health-systems-kingsfund-feb15.pdf. Accessed Sept 2015.

  19. Jolly L. The role of the specialist nurse. Heart 2002; 88(Suppl II):ii33–ii35.

    Google Scholar 

  20. Health and Social Care Information Centre. Prescriptions dispensed in the community, statistics for England—2002—2012 [NS]. 2015. Available from: http://www.hscic.gov.uk/catalogue/PUB11291. Accessed Aug 2015.

  21. European Convention on Human Rights. Council of Europe. 1950. Available from: http://www.echr.coe.int/Documents/Convention_ENG.pdf. Accessed Aug 2015.

  22. Charter of Fundamental Rights of the European Union. The European Parliament, the Council and Commission. 2012. Available from: http://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:12012P/TXT&from=EN. Accessed Aug 2015.

  23. The European Charter of Rights and Responsibilities of older people in need of long term care and assistance. Developed by EUSTaCEA Project, co-financed by the DAPHNE Programme from the Directorate General Justice, Freedom and Securityof the European Commission. 2010. Available from: http://www.age-platform.eu/images/stories/22495_EN_06.pdf. Accessed Sept 2015.

  24. European Medicines Agency, London. Committee on Human Medicinal Products (CHMP). Adequacy of guidance on the elderly regarding medicinal products for human use. 2007. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/01/WC500049541.pdf. Accessed Aug 2015.

  25. International Conference on Harmonisation of Technical Requirements of Pharmaceuticals for Human use, ICH Harmonised Tripartite Guideline. Studies in Special Populations: Geriatric E7. 1993. Available from: http://people.duke.edu/~ghturner/ICH-Guidelines/ICH-E7-Spec-Pops-Geriatrics.pdf. Accessed Aug 2015.

  26. European Medicines Agency, London. EMA geriatric medicines strategy. 2011. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/general/general_content_000249.jsp&mid=WC0b01ac058004cbb9. Accessed Aug 2015.

  27. European Medicines Agency, London. Mandate, objectives and rules of procedure for the CHMP Geriatric Expert group. 2013. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Other/2013/07/WC500145741.pdf. Accessed Aug 2015.

  28. European Medicines Agency, London. EMA Geriatric Medicines Strategy Report analysis of scientific guidelines. 2013. Available from: http://www.ephor.nl/media/1150/scientific-guidelines-geriatric-medicine-strategy-2013.pdf. Accessed Aug 2015.

  29. European Medicines Agency, London. EMA Geriatric Medicines Strategy Report analysis on product information. 2013. Available from: http://www.ephor.nl/media/1146/analysis-product-information-geriatric-medicines-strategy-2013.pdf. Accessed Aug 2015.

  30. Cherubini A1, Oristrell J, Pla X, Ruggiero C, Ferretti R, Diestre G, Clarfield AM, Crome P, Hertogh C, Lesauskaite V, Prada GI, Szczerbinska K, Topinkova E, Sinclair-Cohen J, Edbrooke D, Mills GH. The persistent exclusion of older patients from ongoing clinical trials regarding heart failure. Arch Intern Med. 2011;171(6):550–6.

    Google Scholar 

  31. European Union Geriatric Medicine Society. The Pharmacology Special Interest Group. 2015. Available from: http://www.eugms.org/research-cooperation/special-interest-groups/pharmacology.html. Accessed Sept 2015.

  32. Crome P, Lally F, Cherubini A, Oristrell J, Beswick AD, Clarfield AM, Hertogh C, Lesauskaite V, Prada GI, Szczerbińska K, Topinkova E, Sinclair-Cohen J, Edbrooke D, Mills G. Exclusion of older people from clinical trials: professional views from nine European countries participating in the PREDICT study. Drugs Aging. 2011;28(8):667–77.

    Article  PubMed  Google Scholar 

  33. Bartlam B, Crome P, Lally F, Beswick AD, Cherubini AM, Edbrooke D, Farre A, Hertogh C, Lesaudkaite V, Mills G, Muller M, Oristrell J, Prada GI, Ruggiero C, Sinclair-Cohen J, Szczerbinska K, Topinkova E, Zalewski Z. The views of older people and carers on participation in clinical trials. Clinical Investigation 2012;2:327–336.

    Google Scholar 

  34. EFGCP Geriatric Medicines Working Party (GMWP). Medical research for and with older people in Europe. 2013. Available from: https://www.kcl.ac.uk/sspp/departments/sshm/news/EFGCP-GMWP-Research-Guidelines-Final-edited-2013-05-27.pdf. Accessed Sept 2015.

  35. Campanelli CM. American geriatrics society 2012 beers criteria update expert panel: American geriatrics society updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60:616–31.

    Article  PubMed Central  Google Scholar 

  36. Gallagher P, et al. Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals. Eur J Clin Pharmacol. 2011; 67(11):1175–88.

    Google Scholar 

  37. O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.

    Google Scholar 

  38. Garfinkel D, Zur-Gil S, Ben-Israel J. The war against polypharmacy: a new cost-effective geriatric-palliative approach for improving drug therapy in disabled elderly people. Israel Med Assoc J. 2010;9:430–4.

    Google Scholar 

  39. Garfinkel D, Mangin D. Feasibility study of a systematic approach for discontinuation of multiple medications in older adults. Arch Intern Med. 2010;170:1648–54.

    Article  PubMed  Google Scholar 

  40. Scott IA, Hilmer SN, Reeve E, Potter K, Le Couter D, Rigby D, Gnjidic D, Del Mar CB, Roughead EE, Page A, Jansen J, Martin JH. Reducing inappropriate polypharmacy. The process of deprescribing. JAMA. 2015;175:827–34.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research department of Primary Care and Population Health, Honorary Consultant Royal Free Hospital, University College London, London, UK

    Peter Crome

  2. Geriatric Medicine and General Internal Medicine, Royal Free Hospital, North London Deanery, London, UK

    Joanna Pleming

Authors
  1. Peter Crome
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joanna Pleming
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joanna Pleming .

Editor information

Editors and Affiliations

  1. Graz University of Technology, Graz, Austria

    Sven Stegemann

Rights and permissions

Reprints and permissions

Copyright information

© 2016 American Association of Pharmaceutical Scientists

About this chapter

Cite this chapter

Crome, P., Pleming, J. (2016). Healthcare Provision in an Aging Society—The European Perspective. In: Stegemann, S. (eds) Developing Drug Products in an Aging Society. AAPS Advances in the Pharmaceutical Sciences Series, vol 26. Springer, Cham. https://doi.org/10.1007/978-3-319-43099-7_2

Download citation

Publish with us

Policies and ethics

Search

Navigation